Compugen (CGEN) director Anat Cohen-Dayag reports initial share and option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Compugen Ltd director Anat Cohen-Dayag has filed an initial ownership report showing existing equity holdings in the company. She holds 108,622 Ordinary Shares directly, including 36,091 restricted stock units (RSUs) that vest in 11 equal quarterly installments beginning on March 31, 2026, subject to continued service.
She also holds multiple share options to buy Ordinary Shares, with exercise prices ranging from $1.02 to $14.40 and expiration dates between 2026 and 2035. This filing records current positions and does not report any new purchases or sales of Compugen shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
13 transactions reported
Mixed
13 txns
Insider
Cohen-Dayag Anat
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Share Option (right to buy) — 100,000 shares (Direct);
Ordinary Shares — 108,622 shares (Direct)
Footnotes (1)
- Includes 36,091 restricted stock units ("RSUs"). The RSUs vest in 11 equal quarterly installments commencing on March 31, 2026, subject to the Reporting Person's continued service to the Issuer. Fully vested. This option vested 25% on March 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. This option vested 25% on September 30, 2025 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. This option vests 25% on September 30, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
FAQ
What does Anat Cohen-Dayag’s Form 3 filing for COMPUGEN LTD (CGEN) show?
The Form 3 lists Anat Cohen-Dayag’s existing ownership in Compugen, including ordinary shares, RSUs, and stock options. It is an initial disclosure of her equity position as a director, not a record of recent share purchases or sales.
How many RSUs are included in Anat Cohen-Dayag’s Compugen holdings, and how do they vest?
Her reported holdings include 36,091 restricted stock units (RSUs). These RSUs vest in 11 equal quarterly installments starting on March 31, 2026, contingent on her continued service to Compugen throughout the vesting period described in the filing.
What stock options does Anat Cohen-Dayag report in Compugen’s Form 3 filing?
She holds several share option awards to buy Compugen Ordinary Shares, with exercise prices from $1.02 to $14.40. These options have expiration dates spanning 2026 through 2035, providing long-dated potential ownership if exercised.
What vesting terms are disclosed for Anat Cohen-Dayag’s Compugen stock options?
Footnotes state that some options vested 25% on specific dates, with remaining portions vesting in 12 equal quarterly installments. One grant vests 25% on September 30, 2026, with the rest in 12 quarterly tranches, all conditioned on continued service.